Temporal preference in individuals reporting chronic pain: discounting of delayed pain-related and monetary outcomes.
Temporal preference in individuals reporting chronic pain: discounting of delayed pain-related and monetary outcomes.
复制标题
DOI:
10.1097/j.pain.0000000000000576
复制
发表时间:
2016-08
期刊:
影响因子:
7.4
通讯作者:
Johnson MW
中科院分区:
文献类型:
--
作者:
Tompkins DA;Johnson PS;Smith MT;Strain EC;Edwards RR;Johnson MW
Opioid therapy for pain is associated with an increased risk for substance use disorders (SUD). This study’s purpose was to determine the association between opioid misuse propensity (Screener and Opioid Assessment for Patients in Pain-Revised; SOAPP-R) and delay discounting, a behavioral process linked to SUD which quantifies the extent to which outcomes are devalued due to their delay. Participants reporting chronic pain (PRCP N=249) answered pain and opioid use questions, and then completed four delay discounting tasks. Each of these tasks assessed either money or pain consequences, framed as either rewards or punishments. Each task involved hypothetical choices between immediate smaller vs. delayed larger consequences. The extant Monetary Choice Questionnaire (MCQ) assessed delay discounting of money rewards, and a modified version assessed discounting of money losses (immediate smaller loss vs. larger delayed loss). Based on the MCQ, the novel Pain Relief Choice Questionnaire (PRCQ) assessed choices between an immediate short duration of pain relief vs. a longer duration of pain relief. Similarly, the novel Additional Pain Choice Questionnaire (APCQ) assessed choices between an immediate short duration of additional pain vs. a longer duration of additional pain. Discounting of both additional pain and money losses were significantly associated with high SOAPP-R scores – indicating participants at greatest risk for opioid misuse discount future punishments rather than future rewards compared to those at low risk. Measures of delay discounting may have promise in more accurately identifying individuals at highest risk for opioid misuse during chronic opioid therapy.